Evidence map›Paper›PMID 41372142›Full record

ArticleNature communications2025

RoCK and ROI: single-cell transcriptomics with multiplexed enrichment of selected transcripts and region-specific sequencing.

Giulia Moro, Izaskun Mallona, Malwine J Barz, Joël Maillard, Michael David Brügger, Hassan Fazilaty, Quentin Szabo, Tomas Valenta, Kristina Handler, Fiona Kerlin and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Giulia Moro *Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-0642-6294
Izaskun Mallona *Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland. izaskun.mallona@gmail.com.ORCID http://orcid.org/0000-0002-2853-7526
Malwine J BarzMedical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Joël MaillardDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Michael David BrüggerDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Hassan FazilatyDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-9387-0413
Quentin SzaboDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3539-7875
Tomas ValentaDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3043-1835
Kristina HandlerInstitute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Fiona KerlinBerlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
Lorenz BastianMedical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID http://orcid.org/0000-0002-1487-9437
Claudia D BaldusMedical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID http://orcid.org/0000-0002-0748-834X
Andreas E MoorDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.ORCID http://orcid.org/0000-0001-8715-8449
Robert ZinzenSystems Biology Imaging Technology Platform, Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0002-8638-5102
Mark D RobinsonDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3048-5518
Erich BrunnerDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland. erich.brunner@mls.uzh.ch.ORCID http://orcid.org/0000-0002-9712-9040
Konrad BaslerDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_204869
6 · The paper itself

Abstract

Single-cell profiling technologies allow exploring molecular mechanisms that drive development, health, and disease. However, current methods still fall short of profiling single cell transcriptomes comprehensively, with one major challenge being high non-detection rates of specific transcripts and transcript regions. Such information is often crucial to understanding the biology of cells. Here, we introduce RoCK and ROI (Robust Capture of Key transcripts and Regions Of Interest), a scRNA-seq workflow encompassing two techniques. RoCKseq uses targeted capture to enrich for key transcripts, thereby supporting the detection and identification of cell types and complex phenotypes in scRNA-seq experiments. ROIseq directs a subset of reads to a specific region of interest via selective priming. Importantly, RoCK and ROI enables retrieval of specific sequence information without compromising overall single cell transcriptome information. We validate RoCK and ROI across diverse biological systems highlighting the versatility and showing the power of the method to retrieve critical transcriptomic features.

Indexed as

Gene Expression ProfilingRNA-SeqSequence Analysis, RNASingle-Cell AnalysisTranscriptomeAnimalsHigh-Throughput Nucleotide SequencingHumansMice

Identifiers

PMID41372142
PMCPMC12695968

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.